AMIKACIN
Substance profile for UNII 84319SGC3C, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#
- UNII
- 84319SGC3C
- Preferred term
- AMIKACIN
- Registry number
- 37517-28-5
- EC number
- 253-538-5
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C22H43N5O13

Chemical And Database Identifiers#
- InChIKey
- LKCWBDHBTVXHDL-RMDFUYIESA-N
- SMILES
- NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O
- RxCUI
- 641
- PubChem
- 37768
- NCIt
- C61615
- INN ID
- 3492
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| PubChem Compound | 37768 | https://pubchem.ncbi.nlm.nih.gov/compound/37768 |
| PubChem InChIKey Search | LKCWBDHBTVXHDL-RMDFUYIESA-N | https://pubchem.ncbi.nlm.nih.gov/#query=LKCWBDHBTVXHDL-RMDFUYIESA-N |
| RxNorm | 641 | https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=641 |
| NCI Thesaurus | C61615 | https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61615 |
| FDA Substance Registration System | 84319SGC3C | https://precision.fda.gov/uniisearch/srs/unii/84319SGC3C |
| European Community number | 253-538-5 | https://commonchemistry.cas.org/results?q=253-538-5 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AMIKACIN | ACTIVE MOIETY | 84319SGC3C | Amikacin Sulfate | 1 | |
| AMIKACIN | ACTIVE MOIETY | 84319SGC3C | AMIKACIN SULFATE INJECTION, SOLUTION [HERITAGE PHARMACEUTICALS INC.] | 9 | |
| AMIKACIN | ACTIVE MOIETY | 84319SGC3C | AMIKACIN SULFATE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 8 | |
| AMIKACIN | ACTIVE MOIETY | 84319SGC3C | AMIMAX E (AMIKACIN SULFATE) SOLUTION [BAYER HEALTHCARE LLC] | 5 | |
| AMIKACIN | ACTIVE MOIETY | 84319SGC3C | AMIKACIN SULFATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 3 | |
| AMIKACIN | ACTIVE MOIETY | 84319SGC3C | AMIKACIN SULFATE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 3 |